Comparing Gly(11)/dAla(11)-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the (111)In-SB3/(111)In-SB4 Radiotracer Pair

Background: The GRPR-antagonist (68)Ga-SB3 visualized prostate cancer lesions in animal models and in patients. Switching radiometal from (68)Ga to (111)In impaired tumor targeting in mice, but coinjection of the neprilysin (NEP)-inhibitor phosphoramidon (PA) stabilized (111)In-SB3 in circulation an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lymperis, Emmanouil, Kaloudi, Aikaterini, Kanellopoulos, Panagiotis, de Jong, Marion, Krenning, Eric P., Nock, Berthold A., Maina, Theodosia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471467/
https://www.ncbi.nlm.nih.gov/pubmed/30871262
http://dx.doi.org/10.3390/molecules24061015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471467/
https://www.ncbi.nlm.nih.gov/pubmed/30871262
http://dx.doi.org/10.3390/molecules24061015

Ejemplares similares